Furthermore, longitudinal studies have demonstrated that elevated baseline CRP is associated with an increased risk of cognitive decline and AD development, potentially through sustained IL-6-mediated inflammatory signaling and vascular injury pathways [3]. The gene discussed is IL6; the disease is Alzheimer disease.